Tofacitinib versus Methotrexate in Rheumatoid Arthritis

被引：11
|
作者：
Sexton, Donal [1 ]
机构：
[1] Natl Univ Ireland, Galway, Ireland
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2014年 / 371卷 / 12期
关键词：
RENAL-FUNCTION; DISEASE;
D O I：
10.1056/NEJMc1408607
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1163 / 1163
页数：1
相关论文
共 50 条
  • [31] Tofacitinib versus methotrexate in rheumatoid arthritis: patient-reported outcomes from the randomised phase III ORAL Start trial
    Strand, Vibeke
    Lee, Eun Bong
    Fleischmann, Roy
    Alten, Rieke E.
    Koncz, Tamas
    Zwillich, Samuel H.
    Gruben, David
    Wilkinson, Bethanie
    Krishnaswami, Sriram
    Wallenstein, Gene
    RMD OPEN, 2016, 2 (02):
  • [32] DIACEREIN IN COMBINATION WITH METHOTREXATE VERSUS METHOTREXATE ALONE IN THE TREATMENT OF EARLY RHEUMATOID ARTHRITIS
    Louthrenoo, W.
    Nilganuwong, S.
    Nanagara, R.
    Siripaitoon, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 262 - 262
  • [33] TOFACITINIB WITH AND WITHOUT METHOTREXATE VERSUS ADALIMUMAB WITH METHOTREXATE FOR THE TREATMENT OF RHEUMATOID ARTHRITIS: RESULTS FROM ORAL STRATEGY, A PHASE 3B/4 RANDOMISED TRIAL
    Fleischmann, R.
    Mysler, E.
    Hall, S.
    Kivitz, A.
    Moots, R.
    Luo, Z.
    Tatulych, S.
    DeMasi, R.
    Soma, K.
    Zhang, R.
    Takiya, L.
    Mojcik, C.
    Krishnaswami, S.
    Menon, S.
    Smolen, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 149 - 150
  • [34] Time to Discontinuation of Tofacitinib and TNF Inhibitors in Rheumatoid Arthritis Patients with and Without Methotrexate: Real World Results from a Rheumatoid Arthritis Cohort
    Movahedi, Mohammad
    Cesta, Angela
    Li, Xiuying
    Keystone, Edward C.
    Bombardier, Claire
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [35] Patient-reported outcomes for tofacitinib with and without methotrexate, or adalimumab with methotrexate, in rheumatoid arthritis: a phase IIIB/IV trial
    Strand, Vibeke
    Mysler, Eduardo
    Moots, Robert J.
    Wallenstein, Gene, V
    DeMasi, Ryan
    Gruben, David
    Soma, Koshika
    Iikuni, Noriko
    Smolen, Josef S.
    Fleischmann, Roy
    RMD OPEN, 2019, 5 (02):
  • [36] Analysis of Disease Activity Metrics in a Methotrexate Withdrawal Study among Patients with Rheumatoid Arthritis Treated with Tofacitinib plus Methotrexate
    Fleischmann, Roy
    Haraoui, Boulos
    Buch, Maya H.
    Gold, David
    Sawyerr, Gosford
    Shi, Harry
    Diehl, Annette
    Lee, Kristen
    RHEUMATOLOGY AND THERAPY, 2023, 10 (02) : 375 - 386
  • [37] Methotrexate in rheumatoid arthritis
    Swierkot, Jerzy
    Szechinski, Jacek
    PHARMACOLOGICAL REPORTS, 2006, 58 (04) : 473 - 492
  • [38] Impact of Methotrexate Discontinuation, Interruption, or Persistence in US Patients with Rheumatoid Arthritis Initiating Tofacitinib plus Oral Methotrexate Combination
    Cohen, Stanley B.
    Haraoui, Boulos
    Curtis, Jeffrey R.
    Smith, Timothy W.
    Woolcott, John
    Gruben, David
    Murray, Christopher W.
    CLINICAL THERAPEUTICS, 2022, 44 (07) : 982 - +
  • [39] Analysis of Disease Activity Metrics in a Methotrexate Withdrawal Study among Patients with Rheumatoid Arthritis Treated with Tofacitinib plus Methotrexate
    Roy Fleischmann
    Boulos Haraoui
    Maya H. Buch
    David Gold
    Gosford Sawyerr
    Harry Shi
    Annette Diehl
    Kristen Lee
    Rheumatology and Therapy, 2023, 10 : 375 - 386
  • [40] ECONOMIC EVALUATION OF TOFACITINIB AS INITIAL MEDICATION IN ADULTS WITH RHEUMATOID ARTHRITIS AFTER FAILURE TO METHOTREXATE IN CHILE
    Velasquez, Z. M.
    Bustos Medina, L.
    De la Puente, A. C.
    Zaror, S. C.
    Gutierrez-Ardila, M., V
    VALUE IN HEALTH, 2015, 18 (03) : A161 - A161
12345